JD Health: Becoming Bullish On Tailwinds And Catalysts (Rating Upgrade)
Source: SeekingAlpha
2025-02-05 17:08:37 ET
Summary
- I upgrade JD Health to a Buy due to market share growth, favorable policies, and a strong balance sheet.
- JDHIY's sales are projected to rise by 12% this year, driven by online market expansion and the broadening of insurance reimbursement coverage.
- JD Health's operating margin is expected to improve, benefiting from fixed-cost leverage and new offerings.
- JDHIF's cash pile and the potential for dividends or strategic acquisitions present additional catalysts for stock re-rating.
Read the full article on Seeking Alpha
For further details see:
JD Health: Becoming Bullish On Tailwinds And Catalysts (Rating Upgrade)
JD Health International
NASDAQ: JDHIY
JDHIY Trading
1.01% G/L:
$7 Last:
500 Volume:
$6.93 Open:
